Intellia Therapeutics, Inc. (NTLA) vs Pacific Biosciences of Californ (PACB)
Detailed comparison between Intellia Therapeutics, Inc., Pacific Biosciences of Californ.Total Return (%)
Intellia Therapeutics, Inc. (NTLA)Pacific Biosciences of Californ (PACB)
Which stock do you think will perform better?
Intellia Therapeutics, Inc.
NTLA
Pacific Biosciences of Californ
PACB
| Metric | Intellia Therapeutics, Inc. (NTLA) | Pacific Biosciences of Californ (PACB) |
|---|---|---|
| Current Price | $7.23 | $1.32 |
| Change | 0.37 (5.39%) | -0.04 (-2.94%) |
| Market Cap | $0.75B | $0.39B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -1.31 | -1.94 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $28.18 | $3.20 |
| 52-Week Low | $5.90 | $1.08 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-5.25 | $-1.59 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| NTLA | -16.90% | -27.26% | -66.88% | -49.51% | -67.29% | -67.29% |
| PACB | 4.76% | -22.35% | -15.38% | -58.62% | -78.74% | -78.00% |